1,5-Anhydroglucitol in saliva is a noninvasive marker of short-term glycemic control

Journal of Clinical Endocrinology and Metabolism

Volumn 99, Issue 3, 2014, Pages

  Mook Kanamori, Dennis O ^a,b   El Din Selim, Mohammed M ^c   Takiddin, Ahmed H ^c   Al Homsi, Hala ^c   Al Mahmoud, Khoulood A S ^c   Al Obaidli, Amina ^c   Zirie, Mahmoud A ^c   Rowe, Jillian ^a   Yousri, Noha A ^a   Karoly, Edward D ^d   Kocher, Thomas ^e   Gherbi, Wafaa Sekkal ^a   Chidiac, Omar M ^a   Mook Kanamori, Marjonneke J ^a   Kader, Sara Abdul ^a   Al Muftah, Wadha A ^a   McKeon, Cindy ^a   Suhre, Karsten ^a,f  

^a WEILL CORNELL MEDICAL COLLEGE   (Qatar)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c HAMAD MEDICAL CORPORATION   (Qatar)

^d METABOLON INC   (United States)

^e UNIVERSITY MEDICINE GREIFSWALD   (Germany)

^f INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

1,5 ANHYDROSORBITOL; GLUCOSE; HEMOGLOBIN A1C;

ADULT; AGE; AGED; ARAB; ARTICLE; ASIAN; BLOOD LEVEL; BODY MASS; CASE CONTROL STUDY; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; FILIPINO; GENDER; GLUCOSE BLOOD LEVEL; GLUCOSURIA; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; METABOLITE; METABOLOMICS; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; SALIVA LEVEL; SENSITIVITY AND SPECIFICITY; URINE LEVEL;

ADULT; AGED; BIOLOGICAL MARKERS; BLOOD GLUCOSE; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; DEOXYGLUCOSE; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; MASS SPECTROMETRY; METABOLOMICS; MIDDLE AGED; SALIVA; YOUNG ADULT;

EID: 84895809667     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2013-3596     Document Type: Article

References (20)

1. Meisinger C, Strassburger K, Heier M, et al. Prevalence of undiagnosed diabetes and impaired glucose regulation in 35- to 59-year-old individuals in Southern Germany: the KORA F4 Study. Diabet Med. 2010;27:360-362.
2. Age- and sex-specific prevalences of diabetes and impaired glucose regulation in 13 European cohorts. Diabetes Care. 2003;26:61-69.
3. Wong DT. Salivaomics. J Am Dent Assoc. 2012;143:19S-24S.
4. Lalla E, Kunzel C, Burkett S, Cheng B, Lamster IB. Identification of unrecognized diabetes and pre-diabetes in a dental setting. J Dent Res. 2011;90:855-860.
5. Ferrannini E, Natali A, Camastra S, et al. Early metabolic markers of the development of dysglycemia and type 2 diabetes and their physiological significance. Diabetes. 2013;62:1730-1737.
6. Menni C, Fauman E, Erte I, et al. Biomarkers for type 2 diabetes and impaired fasting glucose using a non-targeted metabolomics approach. Diabetes. 2013;62(12):4270-4276.
7. Wang-Sattler R, Yu Z, Herder C, et al. Novel biomarkers for prediabetes identified by metabolomics. Mol Syst Biol. 2012;8:615.
8. Floegel A, Stefan N, Yu Z, et al. Identification of serum metabolites associated with risk of type 2 diabetes using a targeted metabolomic approach. Diabetes. 2013;62:639-648.
9. Nicholson JK, Lindon JC. Systems biology: Metabonomics. Nature. 2008;455:1054-1056.
10. Faresjo T, Faresjo A. To match or not to match in epidemiological studies - same outcome but less power. Int J Environ Res Public Health. 2010;7:325-332.
11. de Graaf MA, Jager KJ, Zoccali C, Dekker FW. Matching, an appealing method to avoid confounding? Nephron Clin Pract. 2011; 118:c315-c318.
12. Evans AM, DeHaven CD, Barrett T, Mitchell M, Milgram E. Integrated, nontargeted ultrahigh performance liquid chromatography/ electrospray ionization tandem mass spectrometry platform for the identification and relative quantification of the small-molecule complement of biological systems. Anal Chem. 2009;81:6656-6667.
13. Suhre K, Meisinger C, Doring A, et al. Metabolic footprint of diabetes: a multiplatform metabolomics study in an epidemiological setting. PLoS One. 2010;5:e13953.
14. Kim WJ, Park CY. 1,5-Anhydroglucitol in diabetes mellitus. Endocrine. 2013;43:33-40.
15. Yamanouchi T, Tachibana Y, Akanuma H, et al. Origin and disposal of 1,5-anhydroglucitol, a major polyol in the human body. Am J Physiol. 1992;263:E268-E273.
16. Tazawa S, Yamato T, Fujikura H, et al. SLC5A9/SGLT4, a new Na+-dependent glucose transporter, is an essential transporter for mannose, 1,5-anhydro-D-glucitol, and fructose. Life Sci. 2005;76:1039-1050. (Pubitemid 39643403)
17. McGill JB, Cole TG, Nowatzke W, et al. Circulating 1,5-anhydroglucitol levels in adult patients with diabetes reflect longitudinal changes of glycemia: a US trial of the GlycoMark assay. Diabetes Care. 2004;27:1859-1865. (Pubitemid 38989223)
18. Liu L, Wan X, Liu J, Huang Z, Cao X, Li Y. Increased 1,5-anhydroglucitol predicts glycemic remission in patients with newly diagnosed type 2 diabetes treated with short-term intensive insulin therapy. Diabetes Tech Ther. 2012;14:756-761.
19. Nowak N, Skupien J, Cyganek K, Matejko B, Malecki MT. 1,5-Anhydroglucitol as a marker of maternal glycaemic control and predictor of neonatal birthweight in pregnancies complicated by type 1 diabetes mellitus. Diabetologia. 2013;56:709-713.
20. Scully T. Diabetes in numbers. Nature. 2012;485:S2-S3.